Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Alogliptin benzoate

Alogliptin benzoate

pharmaceutical raw materials
Alogliptin benzoate structure

Alogliptin benzoate 

structure
  • CAS No:

    850649-62-6

  • Formula:

    C18H21N5O2.C7H6O2

  • Chemical Name:

    Alogliptin benzoate

  • Synonyms:

    Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-,benzoate (1:1);Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-,monobenzoate;SYR 322;Alogliptin benzoate;Nesina;865720-54-3

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

Alogliptin benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.IC50 value: <10 nMTarget: DPP4Alogliptin is an orally administered, anti-diabetic drug in the DPP-4 inhibitor class. A randomized clinical trial reporting in 2011 aimed to determine the efficacy and safety of alogliptin versus placebo and voglibose among newly diagnosed Type 2 diabetes patients in Japan. The main outcome indicated

Alogliptin benzoate Basic Attributes

461.519

461.206299

1592732-453-0

Characteristics

131

2.54458

1

671.2°C at 760 mmHg

359.7ºC

Safety Information

P260, P264, P270, P301+P312, P314, P330, P501

H302

Alogliptin benzoate Use and Manufacturing

Treatment of type 2 diabetes.This product can maintain the levels of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulin-promoting polypeptide (GIP) in the body, promote the secretion of insulin, and thus exert a hypoglycemic effect. The results of a randomized, placebo-controlled clinical trial showed that monotherapy with alogliptin significantly improved glycemic control in patients with type 2 diabetes compared with placebo, did not increase the incidence of hypoglycemia, and was well tolerated. Alogliptin and its pharmaceutical composition are specific and effective DPP-Ⅳ inhibitors after oral administration of sitagliptin and vildagliptin, which provides new and important treatment options for patients with type 2 diabetes. Application prospects.

Drug Function and Efficacy

Alogliptin is a serine protease dipeptidyl peptidase IV (DPP-IV) inhibitor that can maintain the levels of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) in the body, promote insulin secretion, and thus exert a hypoglycemic effect.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • METROCHEM API PRIVATE LTD

    United States United States
    Active
  • HONOUR LAB LTD

    United States United States
    Active
  • RUYUAN HEC PHARM CO LTD

    United States United States
    Active

Recommended Suppliers of Alogliptin benzoate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.